Do body composition parameters correlate with response to targeted therapy in ER+/HER2- metastatic breast cancer patients? Role of sarcopenia and obesity
PurposeTo investigate the association between body composition parameters, sarcopenia, obesity and prognosis in patients with metastatic ER+/HER2- breast cancer under therapy with cyclin-dependent kinase (CDK) 4/6 inhibitors.Methods92 patients with biopsy-proven metastatic ER+/HER2- breast cancer, t...
Main Authors: | Endi Kripa, Veronica Rizzo, Francesca Galati, Giuliana Moffa, Federica Cicciarelli, Carlo Catalano, Federica Pediconi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.987012/full |
Similar Items
-
Preoperative Staging in Breast Cancer: Intraindividual Comparison of Unenhanced MRI Combined With Digital Breast Tomosynthesis and Dynamic Contrast Enhanced-MRI
by: Veronica Rizzo, et al.
Published: (2021-05-01) -
Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study
by: Sara M. Tolaney, et al.
Published: (2022-02-01) -
How to Treat HR+/HER2- Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story
by: Viola Cogliati, et al.
Published: (2022-03-01) -
Digital Mammography (DM) vs. Dynamic Contrast Enhancement-Magnetic Resonance Imaging (DCE-MRI) in Microcalcifications Assessment: A Radiological–Pathological Comparison
by: Federica Cicciarelli, et al.
Published: (2024-05-01) -
Diagnostic Performance of Contrast-Enhanced Digital Mammography versus Conventional Imaging in Women with Dense Breasts
by: Giuliana Moffa, et al.
Published: (2023-07-01)